edoc

Items where Author is "Drevs, J."

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item Type | Refereed
Jump to: 2011 | 2005 | 2003 | 2002
Number of items: 4.

2011

Medinger, M. and Esser, N. and Soltau, J. and Lehmann, K. M. and Konerding, M. A. and Wolloscheck, T. and Ryan, A. J. and Drevs, J.. (2011) Antitumor effect of the vascular-disrupting agent ZD6126 in a murine renal cell carcinoma model. International journal of oncology, 38 (2). pp. 455-464.

2005

Drevs, J. and Zirrgiebel, U. and Schmidt-Gersbach, C. I. M. and Mross, K. and Medinger, M. and Lee, L. and Pinheiro, J. and Wood, J. and Thomas, A. L. and Unger, C. and Henry, A. and Steward, W. P. and Laurent, D. and Lebwohl, D. and Dugan, M. and Marmé, D.. (2005) Soluble markers for the assessment of biological activity with PTK787/ZK 222584 (PTK/ZK), a vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitor in patients with advanced colorectal cancer from two phase I trials. Annals of Oncology, 16 (4). pp. 558-565.

2003

Medinger, M. and Adler, C. P. and Schmidt-Gersbach, C. and Soltau, J. and Droll, A. and Unger, C. and Drevs, J.. (2003) Angiogenesis and the ET-1/ETA receptor system: immunohistochemical expression analysis in bone metastases from patients with different primary tumors. Angiogenesis, 6 (3). pp. 225-231.

2002

Drevs, J. and Laus, C. and Medinger, M. and Schmidt-Gersbach, C. and Unger, C.. (2002) Antiangiogenesis: current clinical data and future perspectives. Onkologie, 25 (6). pp. 520-527.

This list was generated on Fri Mar 29 11:58:18 2024 CET.